Author Correction: HDAC3 inhibition ameliorates spinal cord injury by immunomodulation

Sci Rep. 2018 Apr 27;8(1):6920. doi: 10.1038/s41598-018-25249-3.

Tomoharu Kuboyama^{1

2}, Shalaka Wahane¹, Yong Huang¹, Xiang Zhou¹, Jamie K Wong^{1

3}, Andrew Koemeter-Cox^{1

4}, Michael Martini¹, Roland H Friedel^{1

5}, Hongyan Zou^{6

7}

¹ Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA.
² Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan.
³ Tisch MS Research Center of New York, New York, New York, 10019, USA.
⁴ Alzheimer's Drug Discovery Foundation New York, New York, 10019, USA.
⁵ Department of Neurosurgery, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA.
⁶ Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA. [email protected].
⁷ Department of Neurosurgery, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA. [email protected].

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.